Ultromics raised €28M in a Series B round in Aug 2021. The company is based in Oxford, UK. Investors in the round: Blue Venture Fund, GV, Optum Ventures and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €28M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
